[{"headers": [["CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) shares in Thousands, $ in Millions", "3 Months Ended", "9 Months Ended"], ["Jun. 26, 2021", "Jun. 27, 2020", "Jun. 26, 2021", "Jun. 27, 2020"]], "sections": ["Operating expenses:", "Earnings per share:", "Shares used in computing earnings per share:"], "data": [["Net sales", "$ 81,434", "$ 59,685", "$ 282,457", "$ 209,817"], ["Cost of sales", "46,179", "37,005", "164,795", "129,550"], ["Gross margin", "35,255", "22,680", "117,662", "80,267"], ["Research and development", "5,717", "4,758", "16,142", "13,774"], ["Selling, general and administrative", "5,412", "4,831", "16,357", "14,980"], ["Total operating expenses", "11,129", "9,589", "32,499", "28,754"], ["Operating income", "24,126", "13,091", "85,163", "51,513"], ["Other income/(expense), net", "243", "46", "796", "677"], ["Income before provision for income taxes", "24,369", "13,137", "85,959", "52,190"], ["Provision for income taxes", "2,625", "1,884", "11,830", "7,452"], ["Net income", "$ 21,744", "$ 11,253", "$ 74,129", "$ 44,738"], ["Basic (in dollars per share)", "$ 1.31", "$ 0.65", "$ 4.42", "$ 2.56"], ["Diluted (in dollars per share)", "$ 1.30", "$ 0.65", "$ 4.38", "$ 2.54"], ["Basic (in shares)", "16,629,371", "17,250,291", "16,772,656", "17,450,284"], ["Diluted (in shares)", "16,781,735", "17,419,154", "16,941,527", "17,618,778"], ["Products", "", "", "", ""], ["Net sales", "$ 63,948", "$ 46,529", "$ 232,309", "$ 170,598"], ["Cost of sales", "40,899", "32,693", "149,476", "116,089"], ["Services", "", "", "", ""], ["Net sales", "17,486", "13,156", "50,148", "39,219"], ["Cost of sales", "$ 5,280", "$ 4,312", "$ 15,319", "$ 13,461"]]}, {"headers": [["CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Millions", "Jun. 26, 2021", "Sep. 26, 2020"]], "sections": ["Current assets:", "Non-current assets:", "Current liabilities:", "Non-current liabilities:", "Shareholders\u2019 equity:"], "data": [["Cash and cash equivalents", "$ 34,050", "$ 38,016"], ["Marketable securities", "27,646", "52,927"], ["Accounts receivable, net", "17,475", "16,120"], ["Inventories", "5,178", "4,061"], ["Vendor non-trade receivables", "16,433", "21,325"], ["Other current assets", "13,641", "11,264"], ["Total current assets", "114,423", "143,713"], ["Marketable securities", "131,948", "100,887"], ["Property, plant and equipment, net", "38,615", "36,766"], ["Other non-current assets", "44,854", "42,522"], ["Total non-current assets", "215,417", "180,175"], ["Total assets", "329,840", "323,888"], ["Accounts payable", "40,409", "42,296"], ["Other current liabilities", "43,625", "42,684"], ["Deferred revenue", "7,681", "6,643"], ["Commercial paper", "8,000", "4,996"], ["Term debt", "8,039", "8,773"], ["Total current liabilities", "107,754", "105,392"], ["Term debt", "105,752", "98,667"], ["Other non-current liabilities", "52,054", "54,490"], ["Total non-current liabilities", "157,806", "153,157"], ["Total liabilities", "265,560", "258,549"], ["Commitments and contingencies", "", ""], ["Common stock and additional paid-in capital, $0.00001 par value: 50,400,000 shares authorized; 16,556,942 and 16,976,763 shares issued and outstanding, respectively", "54,989", "50,779"], ["Retained earnings", "9,233", "14,966"], ["Accumulated other comprehensive income/(loss)", "58", "(406)"], ["Total shareholders\u2019 equity", "64,280", "65,339"], ["Total liabilities and shareholders\u2019 equity", "$ 329,840", "$ 323,888"]]}, {"headers": [["CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited) - USD ($) $ in Millions", "Total", "Common stock and additional paid-in capital", "Retained earnings", "Retained earnings \nCumulative effect of change in accounting principle", "Accumulated other comprehensive income/(loss)", "Accumulated other comprehensive income/(loss) \nCumulative effect of change in accounting principle"]], "sections": ["Increase (Decrease) in Stockholders' Equity [Roll Forward]", "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "Increase (Decrease) in Stockholders' Equity [Roll Forward]"], "data": [["Beginning balances at Sep. 28, 2019", "$ 90,488", "$ 45,174", "$ 45,898", "$ (136)", "$ (584)", "$ 136"], ["Common stock issued", "", "430", "", "", "", ""], ["Common stock withheld related to net share settlement of equity awards", "", "(2,123)", "(1,320)", "", "", ""], ["Share-based compensation", "", "5,215", "", "", "", ""], ["Net income", "44,738", "", "44,738", "", "", ""], ["Dividends and dividend equivalents declared", "", "", "(10,528)", "", "", ""], ["Common stock repurchased", "", "", "(54,516)", "", "", ""], ["Other comprehensive income/(loss)", "(102)", "", "", "", "(102)", ""], ["Ending balances at Jun. 27, 2020", "$ 72,282", "48,696", "24,136", "", "(550)", ""], ["Dividends and dividend equivalents declared per share or RSU (in dollars per share or RSU)", "$ 0.59", "", "", "", "", ""], ["Beginning balances at Mar. 28, 2020", "$ 78,425", "48,032", "33,182", "0", "(2,789)", "0"], ["Common stock issued", "", "0", "", "", "", ""], ["Common stock withheld related to net share settlement of equity awards", "", "(1,071)", "(688)", "", "", ""], ["Share-based compensation", "", "1,735", "", "", "", ""], ["Net income", "11,253", "", "11,253", "", "", ""], ["Dividends and dividend equivalents declared", "", "", "(3,611)", "", "", ""], ["Common stock repurchased", "", "", "(16,000)", "", "", ""], ["Other comprehensive income/(loss)", "2,239", "", "", "", "2,239", ""], ["Ending balances at Jun. 27, 2020", "$ 72,282", "48,696", "24,136", "", "(550)", ""], ["Dividends and dividend equivalents declared per share or RSU (in dollars per share or RSU)", "$ 0.205", "", "", "", "", ""], ["Beginning balances at Sep. 26, 2020", "$ 65,339", "50,779", "14,966", "0", "(406)", "0"], ["Common stock issued", "", "561", "", "", "", ""], ["Common stock withheld related to net share settlement of equity awards", "", "(2,460)", "(3,606)", "", "", ""], ["Share-based compensation", "", "6,109", "", "", "", ""], ["Net income", "74,129", "", "74,129", "", "", ""], ["Dividends and dividend equivalents declared", "", "", "(10,755)", "", "", ""], ["Common stock repurchased", "(65,500)", "", "(65,501)", "", "", ""], ["Other comprehensive income/(loss)", "464", "", "", "", "464", ""], ["Ending balances at Jun. 26, 2021", "$ 64,280", "54,989", "9,233", "", "58", ""], ["Dividends and dividend equivalents declared per share or RSU (in dollars per share or RSU)", "$ 0.63", "", "", "", "", ""], ["Beginning balances at Mar. 27, 2021", "$ 69,178", "54,203", "15,261", "$ 0", "(286)", "$ 0"], ["Common stock issued", "", "0", "", "", "", ""], ["Common stock withheld related to net share settlement of equity awards", "", "(1,224)", "(1,559)", "", "", ""], ["Share-based compensation", "", "2,010", "", "", "", ""], ["Net income", "21,744", "", "21,744", "", "", ""], ["Dividends and dividend equivalents declared", "", "", "(3,713)", "", "", ""], ["Common stock repurchased", "", "", "(22,500)", "", "", ""], ["Other comprehensive income/(loss)", "344", "", "", "", "344", ""], ["Ending balances at Jun. 26, 2021", "$ 64,280", "$ 54,989", "$ 9,233", "", "$ 58", ""], ["Dividends and dividend equivalents declared per share or RSU (in dollars per share or RSU)", "$ 0.22", "", "", "", "", ""]]}, {"headers": [["CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Millions", "9 Months Ended"], ["Jun. 26, 2021", "Jun. 27, 2020"]], "sections": ["Statement of Cash Flows [Abstract]", "Operating activities:", "Adjustments to reconcile net income to cash generated by operating activities:", "Changes in operating assets and liabilities:", "Investing activities:", "Financing activities:", "Supplemental cash flow disclosure:"], "data": [["Cash, cash equivalents and restricted cash, beginning balances", "$ 39,789", "$ 50,224"], ["Net income", "74,129", "44,738"], ["Depreciation and amortization", "8,295", "8,354"], ["Share-based compensation expense", "5,961", "5,105"], ["Deferred income tax expense/(benefit)", "(737)", "182"], ["Other", "(689)", "(94)"], ["Accounts receivable, net", "(1,316)", "5,149"], ["Inventories", "(1,213)", "10"], ["Vendor non-trade receivables", "4,892", "8,685"], ["Other current and non-current assets", "(5,899)", "(6,760)"], ["Accounts payable", "(1,786)", "(10,787)"], ["Deferred revenue", "1,738", "1,649"], ["Other current and non-current liabilities", "463", "3,867"], ["Cash generated by operating activities", "83,838", "60,098"], ["Purchases of marketable securities", "(94,052)", "(96,606)"], ["Proceeds from maturities of marketable securities", "49,880", "54,865"], ["Proceeds from sales of marketable securities", "36,745", "39,760"], ["Payments for acquisition of property, plant and equipment", "(7,862)", "(5,525)"], ["Payments made in connection with business acquisitions, net", "(13)", "(1,473)"], ["Other", "(78)", "(841)"], ["Cash used in investing activities", "(15,380)", "(9,820)"], ["Proceeds from issuance of common stock", "561", "430"], ["Payments for taxes related to net share settlement of equity awards", "(5,855)", "(3,234)"], ["Payments for dividends and dividend equivalents", "(10,827)", "(10,570)"], ["Repurchases of common stock", "(66,223)", "(55,171)"], ["Proceeds from issuance of term debt, net", "13,923", "10,635"], ["Repayments of term debt", "(7,500)", "(12,629)"], ["Proceeds from commercial paper, net", "3,022", "31"], ["Proceeds from repurchase agreements", "0", "5,165"], ["Other", "(72)", "(120)"], ["Cash used in financing activities", "(72,971)", "(65,463)"], ["Decrease in cash, cash equivalents and restricted cash", "(4,513)", "(15,185)"], ["Cash, cash equivalents and restricted cash, ending balances", "35,276", "35,039"], ["Cash paid for income taxes, net", "18,536", "8,410"], ["Cash paid for interest", "$ 1,870", "$ 2,275"]]}]